X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (66149) 66149
Magazine Article (147) 147
Book Chapter (143) 143
Dissertation (87) 87
Publication (56) 56
Conference Proceeding (44) 44
Book / eBook (35) 35
Web Resource (29) 29
Book Review (6) 6
Newsletter (6) 6
Reference (4) 4
Newspaper Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (53106) 53106
science & technology (34389) 34389
life sciences & biomedicine (33587) 33587
male (26586) 26586
female (21948) 21948
platelet aggregation - drug effects (20985) 20985
platelet aggregation inhibitors - therapeutic use (18633) 18633
platelet aggregation (16782) 16782
middle aged (15845) 15845
animals (15474) 15474
cardiovascular system & cardiology (13571) 13571
aged (12968) 12968
adult (10905) 10905
platelet aggregation inhibitors - pharmacology (9256) 9256
abridged index medicus (9077) 9077
cardiac & cardiovascular systems (8664) 8664
blood platelets - drug effects (8249) 8249
platelet aggregation inhibitors - administration & dosage (7523) 7523
ticlopidine - analogs & derivatives (7309) 7309
treatment outcome (7198) 7198
aspirin - therapeutic use (6945) 6945
blood platelets - metabolism (6798) 6798
risk factors (6611) 6611
peripheral vascular disease (6455) 6455
platelet aggregation inhibitors - adverse effects (6427) 6427
hematology (6397) 6397
time factors (5591) 5591
pharmacology & pharmacy (5111) 5111
aspirin (5007) 5007
blood platelets - physiology (4742) 4742
in vitro techniques (4729) 4729
ticlopidine - therapeutic use (4544) 4544
rats (4512) 4512
platelets (4401) 4401
adenosine diphosphate - pharmacology (4329) 4329
drug therapy, combination (4290) 4290
anticoagulants - therapeutic use (4043) 4043
dose-response relationship, drug (3860) 3860
clopidogrel (3633) 3633
general & internal medicine (3574) 3574
aspirin - administration & dosage (3567) 3567
blood platelets (3465) 3465
thrombosis (3423) 3423
aged, 80 and over (3405) 3405
stents (3304) 3304
rabbits (3281) 3281
medicine, general & internal (3249) 3249
aspirin - pharmacology (3077) 3077
prospective studies (2983) 2983
platelet aggregation - physiology (2696) 2696
mice (2683) 2683
collagen - pharmacology (2553) 2553
retrospective studies (2503) 2503
surgery (2489) 2489
ticlopidine - administration & dosage (2406) 2406
stroke (2346) 2346
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (2310) 2310
follow-up studies (2306) 2306
aspirin - adverse effects (2300) 2300
drug therapy (2272) 2272
platelet aggregation inhibitors (2259) 2259
neurosciences & neurology (2254) 2254
analysis (2228) 2228
care and treatment (2200) 2200
thrombosis - prevention & control (2200) 2200
fibrinolytic agents - therapeutic use (2196) 2196
anticoagulants (2181) 2181
biochemistry & molecular biology (2169) 2169
hemorrhage - chemically induced (2156) 2156
ticlopidine - adverse effects (2130) 2130
platelet count (2125) 2125
adolescent (2120) 2120
risk assessment (2115) 2115
platelet function tests (2068) 2068
myocardial infarction - drug therapy (2047) 2047
platelet activation - drug effects (2042) 2042
cardiology (2034) 2034
cardiovascular disease (1989) 1989
angioplasty, balloon, coronary (1971) 1971
cardiovascular (1947) 1947
heart attacks (1929) 1929
stroke - prevention & control (1848) 1848
aggregation (1826) 1826
thrombin - pharmacology (1816) 1816
randomized controlled trials as topic (1809) 1809
clinical neurology (1772) 1772
cardiovascular diseases (1745) 1745
thrombosis - etiology (1705) 1705
percutaneous coronary intervention (1683) 1683
anticoagulants - adverse effects (1642) 1642
coronary heart disease (1616) 1616
double-blind method (1614) 1614
research (1614) 1614
blood coagulation - drug effects (1612) 1612
medicine & public health (1573) 1573
dogs (1550) 1550
kinetics (1538) 1538
mortality (1538) 1538
myocardial infarction - therapy (1537) 1537
clinical trials as topic (1519) 1519
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (59495) 59495
Japanese (1931) 1931
German (1807) 1807
Russian (1695) 1695
French (1114) 1114
Chinese (775) 775
Spanish (748) 748
Italian (667) 667
Polish (313) 313
Portuguese (263) 263
Dutch (104) 104
Czech (96) 96
Hungarian (83) 83
Danish (73) 73
Korean (60) 60
Turkish (56) 56
Swedish (47) 47
Norwegian (41) 41
Ukrainian (34) 34
Hebrew (32) 32
Serbian (30) 30
Croatian (29) 29
Romanian (27) 27
Slovak (25) 25
Bulgarian (17) 17
Finnish (17) 17
Lithuanian (15) 15
Icelandic (4) 4
Bosnian (2) 2
Latvian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 01/2008, Volume 51, Issue 3, pp. 256 - 260
Journal Article
The New England journal of medicine, ISSN 1533-4406, 03/2017, Volume 376, Issue 13, pp. 1211 - 1222
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2008, Volume 359, Issue 12, pp. 1238 - 1251
In this large clinical trial, aspirin plus extended-release dipyridamole was found to have an efficacy similar to that of clopidogrel in the prevention of... 
ACTIVE CONTROLLED-TRIALS | HIGH-RISK PATIENTS | TICLOPIDINE | TRANSIENT ISCHEMIC ATTACK | DOUBLE-BLIND | PREVENTION | RANDOMIZED CONTROLLED-TRIAL | ARTERIAL ORIGIN ESPRIT | CEREBRAL-ISCHEMIA | UMCG Approved | NON-INFERIORITY TRIALS | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Myocardial Infarction - epidemiology | Benzoates - therapeutic use | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Risk | Secondary Prevention | Aspirin - administration & dosage | Vascular Diseases - mortality | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Dipyridamole - adverse effects | Female | Stroke - epidemiology | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Dipyridamole - therapeutic use | Benzimidazoles - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Brain Ischemia - epidemiology | Stroke - prevention & control | Double-Blind Method | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Ischemia - prevention & control | Factor Analysis, Statistical | Stroke - drug therapy | Ticlopidine - analogs & derivatives | Aged | Hemorrhage - chemically induced | Delayed-Action Preparations | Stroke (Disease) | Aspirin | Usage | Care and treatment | Dipyridamole | Clopidogrel | Health aspects | Stroke | Index Medicus | Abridged Index Medicus | Recurrence | Brain Ischemia | Benzimidazoles | Follow-Up Studies | Neurons and Cognition | Cognition | Hemorrhage | Drug Delivery Systems | Life Sciences | Angiotensin II Type 1 Receptor Blockers | Angiotensin-Converting Enzyme Inhibitors | Vascular Diseases | Mental Status Schedule | Retrospective Studies | Severity of Illness Index | Disability Evaluation | Benzoates | Drug Administration Schedule | International Cooperation | Ticlopidine | Myocardial Infarction | Platelet Aggregation Inhibitors | Santé publique et épidémiologie | Original | Dipyridamole/adverse effects/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Recurrence/prevention & control | Benzoates/therapeutic use | Brain Ischemia/epidemiology/prevention & control | MEDICIN OCH HÄLSOVETENSKAP | Platelet Aggregation Inhibitors/administration & dosage/adverse | Combination | MEDICAL AND HEALTH SCIENCES | Aspirin/administration & dosage/adverse effects | Myocardial Infarction/epidemiology | Factor Analysis | Benzimidazoles/therapeutic use | Drug Therapy | Ticlopidine/adverse effects/analogs & derivatives/therapeutic use | effects/therapeutic use | Vascular Diseases/mortality | Hemorrhage/chemically induced | Stroke/drug therapy/epidemiology/prevention & control | Statistical | Kaplan-Meiers Estimate
Journal Article
The New England journal of medicine, ISSN 1533-4406, 01/2009, Volume 360, Issue 4, pp. 354 - 362
Journal Article
by Anand, Sonia S and Bosch, Jackie and Eikelboom, John W and Connolly, Stuart J and Aboyans, Victor and Alings, Marco and Kakkar, Ajay K and Lewis, Basil S and Störk, Stefan and Zhu, Jun and Lopez-Jaramillo, Patricio and O'Donnell, Martin and Commerford, Patrick J and Vinereanu, Dragos and Ryden, Lars and Misselwitz, Frank and Varigos, John D and Vanassche, Thomas and Chen, Edmond and Branch, Kelley and Leong, Darryl P and Bangdiwala, Shrikant I and Hart, Robert G and Yusuf, Salim and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and VOGEL, DANIEL and HRABAR, ADRIAN and CUNEO, CARLOS and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and CARDONA, MARCELO and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and ABRANTES, JOSE ANTONIO and MANENTI, EULER and MAIA, LILIA and HERNANDES, MAURO and ROSSI DOS SANTOS, FABIO and ZIMMERMANN, SERGIO LUIZ and ABIB JR, EDUARDO and LEAES, PAULO and BOTELHO, ROBERTO and BRAILE, MARIA and IZUKAWA, NILO and TANAJURA, LUIZ FERNANDO and SERRANO JUNIOR, CARLOS VICENTE and NASI, LUIZ ANTONIO and TYTUS, RICHARD and PANDEY, SHEKHAR and LONN, EVA and CHA, JAMES and BABAPULLE, MOHAN and LAMY, ANDRE and KIAII, BOB and BHARGAVA, RAKESH and MEHTA, PRAVINSAGAR and HILL, LAURIE and FELL, DAVID and LAM, ANDY and AL-QOOFI, FAISAL and PETRELLA, ROBERT and GLANZ, ANTHONY and NOISEUX, NICOLAS and MERALI, FATIMA and ... and COMPASS Investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The Lancet (British edition), ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 219 - 229
Patients with peripheral artery disease have an increased risk of cardiovascular morbidity and mortality. Antiplatelet agents are widely used to reduce these... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Carotid Artery Diseases - complications | Male | Peripheral Arterial Disease - complications | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Lower Extremity - surgery | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Rivaroxaban - therapeutic use | Carotid Artery Diseases - drug therapy | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Peripheral Arterial Disease - drug therapy | Carotid Artery Diseases - epidemiology | Morbidity | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Peripheral Arterial Disease - epidemiology | Factor Xa Inhibitors - adverse effects | Aged | Myocardial Infarction - prevention & control | Amputation - statistics & numerical data | Hemorrhage - chemically induced | Lower Extremity - blood supply | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Heart attacks | Medical imaging | Mortality | Clinical trials | Cardiovascular disease | Patients | Disease control | Evidence-based medicine | Carotid arteries | Disease prevention | Coronary vessels | Blood pressure | Carotid artery | Acute coronary syndromes | Thromboembolism | Health risk assessment | Index Medicus | Abridged Index Medicus | Cardiovascular Diseases | Factor Xa Inhibitors | Klinisk medicin | Hemorrhage | epidemiology | Rivaroxaban | administration & dosage | Combination | Amputation | Drug | drug therapy | chemically induced | complications | prevention & control | Peripheral Arterial Disease | etiology | Clinical Medicine | Myocardial Infarction | statistics & numerical data | blood supply | Carotid Artery Diseases | Platelet Aggregation Inhibitors | adverse effects | mortality | Lower Extremity | Dose-Response Relationship | therapeutic use | surgery
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 08/2009, Volume 302, Issue 8, pp. 849 - 857
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2012, Volume 366, Issue 15, pp. 1404 - 1413
Patients with atherosclerotic vascular disease were randomly assigned to receive the thrombin antagonist vorapaxar or placebo. Vorapaxar reduced the rate of... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Risk | Secondary Prevention | Pyridines - adverse effects | Cardiovascular Diseases - mortality | Female | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Pyridines - therapeutic use | Double-Blind Method | Hemorrhage - epidemiology | Receptor, PAR-1 - antagonists & inhibitors | Kaplan-Meier Estimate | Peripheral Arterial Disease - drug therapy | Stroke - drug therapy | Lactones - adverse effects | Lactones - therapeutic use | Retreatment | Myocardial Infarction - drug therapy | Brain Ischemia - drug therapy | Intracranial Hemorrhages - chemically induced | Intracranial Hemorrhages - epidemiology | Aged | Hemorrhage - chemically induced | Prevention | Drugs | Aggregation | Dose-response relationship (Biochemistry) | Atheroembolism | Blood platelets | Atherosclerosis | Product/Service Evaluations | Dosage and administration | Drug therapy | Myocardial infarction | Cerebral infarction | Stroke | Aspirin | Heart attacks | Proteinase-activated receptor 1 | Thrombin | Hemorrhage | Patients | Bleeding | Disease prevention | Ischemia | Arteriosclerosis | Death | Cardiovascular diseases | Health risk assessment | Index Medicus | Abridged Index Medicus | Computer Science | Medical Imaging
Journal Article